Table 2

Types of clinical practice documents

Clinical practice guidelinesExpert consensus statementsClinical statements/white papers
DefinitionEvidence-based documents containing systematically developed recommendations with an explicit clinical scope and explicit consideration of benefits, harms, values, and preferences.Expert position on a controversial or specific clinical topic, formulated as a statement of facts based on available evidence and expert consensus in situations where high-level evidence is unavailable.Extensive reports outlining positions on critical clinical issues while highlighting areas of ongoing uncertainty or concern for patient safety.
Source of evidenceRandomized controlled trials (RCTs) are available and serve as the primary source of information; observational data are used if considered robust.Robust observational data are available and serve as the primary source of information in conjunction with a limited number of RCTs.Any research and health care regulations
Number of writing committee membersUp to 20Up to 20Up to 10
ReviewFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, up to 3 anonymous reviewers from each participating entity
LengthUp to 30,000 words and a total of 500 referencesUp to 15,000 words and a total of 300 referencesUp to 5000 words and a total of 50 references
Time frame24 months12 months6 months
Clinical practice guidelinesExpert consensus statementsClinical statements/white papers
DefinitionEvidence-based documents containing systematically developed recommendations with an explicit clinical scope and explicit consideration of benefits, harms, values, and preferences.Expert position on a controversial or specific clinical topic, formulated as a statement of facts based on available evidence and expert consensus in situations where high-level evidence is unavailable.Extensive reports outlining positions on critical clinical issues while highlighting areas of ongoing uncertainty or concern for patient safety.
Source of evidenceRandomized controlled trials (RCTs) are available and serve as the primary source of information; observational data are used if considered robust.Robust observational data are available and serve as the primary source of information in conjunction with a limited number of RCTs.Any research and health care regulations
Number of writing committee membersUp to 20Up to 20Up to 10
ReviewFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, up to 3 anonymous reviewers from each participating entity
LengthUp to 30,000 words and a total of 500 referencesUp to 15,000 words and a total of 300 referencesUp to 5000 words and a total of 50 references
Time frame24 months12 months6 months
Table 2

Types of clinical practice documents

Clinical practice guidelinesExpert consensus statementsClinical statements/white papers
DefinitionEvidence-based documents containing systematically developed recommendations with an explicit clinical scope and explicit consideration of benefits, harms, values, and preferences.Expert position on a controversial or specific clinical topic, formulated as a statement of facts based on available evidence and expert consensus in situations where high-level evidence is unavailable.Extensive reports outlining positions on critical clinical issues while highlighting areas of ongoing uncertainty or concern for patient safety.
Source of evidenceRandomized controlled trials (RCTs) are available and serve as the primary source of information; observational data are used if considered robust.Robust observational data are available and serve as the primary source of information in conjunction with a limited number of RCTs.Any research and health care regulations
Number of writing committee membersUp to 20Up to 20Up to 10
ReviewFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, up to 3 anonymous reviewers from each participating entity
LengthUp to 30,000 words and a total of 500 referencesUp to 15,000 words and a total of 300 referencesUp to 5000 words and a total of 50 references
Time frame24 months12 months6 months
Clinical practice guidelinesExpert consensus statementsClinical statements/white papers
DefinitionEvidence-based documents containing systematically developed recommendations with an explicit clinical scope and explicit consideration of benefits, harms, values, and preferences.Expert position on a controversial or specific clinical topic, formulated as a statement of facts based on available evidence and expert consensus in situations where high-level evidence is unavailable.Extensive reports outlining positions on critical clinical issues while highlighting areas of ongoing uncertainty or concern for patient safety.
Source of evidenceRandomized controlled trials (RCTs) are available and serve as the primary source of information; observational data are used if considered robust.Robust observational data are available and serve as the primary source of information in conjunction with a limited number of RCTs.Any research and health care regulations
Number of writing committee membersUp to 20Up to 20Up to 10
ReviewFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, a lead reviewer and up to 5 anonymous reviewers from each participating entity in collaboration with the governing bodiesFollowing the writing committee's established composition principles, up to 3 anonymous reviewers from each participating entity
LengthUp to 30,000 words and a total of 500 referencesUp to 15,000 words and a total of 300 referencesUp to 5000 words and a total of 50 references
Time frame24 months12 months6 months
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close